# ENFLONSIA

NDC: 0006-5073
Generic name: CLESROVIMAB
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20250609

FDA application: BLA761432

## Active ingredients

- CLESROVIMAB: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-5073"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5073
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9004a92-40e8-4cdb-b22d-d07929f8fc3b
